Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7703365 | 1.00 | FNTA (0.48) | FNTAFNTB | |
| SCHEMBL8198535 | 0.94 | FNTA (0.54) | FNTAFNTB | |
| SCHEMBL8205645 | 0.94 | FNTA (0.54) | FNTAFNTB | |
| SCHEMBL8213988 | 0.92 | FNTA (0.43) | FNTAFNTB | |
| SCHEMBL7706173 | 0.91 | FNTA (0.51) | FNTAFNTB | |
| SCHEMBL7706180 | 0.91 | FNTA (0.51) | FNTAFNTB | |
| SCHEMBL7708966 | 0.91 | FNTA (0.39) | FNTAFNTB | |
| SCHEMBL7703446 | 0.91 | FNTA (0.48) | FNTAFNTB | |
| SCHEMBL7703452 | 0.91 | FNTA (0.48) | FNTAFNTB | |
| SCHEMBL7706068 | 0.90 | FNTA (0.40) | FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6414145-B1 | TREATING CANCER AND NEUROFIBROMATOSIS | ZENECA LIMITED (GB) | 2002-07-02 | — | — | US | claimed |
| US-6414145-B1 | TREATING CANCER AND NEUROFIBROMATOSIS | ZENECA LIMITED (GB) | 2002-07-02 | — | — | US | disclosed |
| EP-1054865-A1 | FARNESYL TRANSFERASE INHIBITORS | AstraZeneca UK Limited (GB) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999041235-A1 | FARNESYL TRANSFERASE INHIBITORS | ASTRAZENECA UK LIMITED (GB) | 1999-08-19 | — | — | WO | disclosed |